Drug Trial Radar · NCT01866111
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Last checked: Nov 19, 2026Latest source record: Jun 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
437
Actual
Start
Jul 31, 2013
Primary completion
Apr 5, 2021
Study completion Oct 31, 2021
Sponsor
- Lead sponsor
- SK Life Science, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 31, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, double-blind, randomized, placebo-controlled dose response study, with an 8-week prospective baseline and an 18 week double-blind treatment period (including a 6-week titration phase and 12 week maintenance phase), followed by a 3-week blinded study drug taper period (for subjects leaving the study) or a 2-week blinded conversion period (for subjects who will participate in the open-label extension). The primary objective of this study is to determine the effective dose range of YKP3089 as adjunctive therapy for the treatment of partial seizures. The trial will also evaluate the safety and tolerability of YKP3089 in the partial epilepsy population.
Conditions
- Partial Epilepsy
Interventions
YKP3089Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Partial-onset Seizure Frequency Per 28 DaysTime frame: baseline and 18 weeks
Locations
67 sites in 15 countries. Site status is shown where the registry gives one.
St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics
Phoenix, Arizona
Clinical Trials, Inc.
Little Rock, Arkansas
Kaiser Permanente, Department of Neurology
Anaheim, California
Neuro-Pain Medical Center
Fresno, California
West Los Angeles VA Medical Center, Clinical Research Center
Los Angeles, California
Neuroresearch, Inc. - Torrance
Torrance, California
Neuroresearch II, Inc.
Ventura, California
Bradenton Research Center, Inc.
Bradenton, Florida
Lovelace Scientific Resources, Inc.
Sarasota, Florida
Consultants in Epilepsy & Neurology, PLLC
Boise, Idaho
Johns Hopkins University
Baltimore, Maryland
Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland
Neurology Clinic PC
Waldorf, Maryland
The Comprehensive Epilepsy Care Center for Children and Adults
St Louis, Missouri
Northeast Regional Epilepsy Group
Hackensack, New Jersey
NYU Comprehensive Epilepsy Center
New York, New York
The Neurological Institute, PA
Charlotte, North Carolina
Thomas Jefferson Comprehensive Epilepsy Center
Philadelphia, Pennsylvania
Vanderbilt Epilepsy Clinic
Nashville, Tennessee
Austin Epilepsy Care Center
Austin, Texas
University of Virginia Comprehensive Epilepsy Program
Charlottesville, Virginia
Institute of Neurological Sciences, Prince of Wales Hospital
Randwick, New South Wales, Australia
Monash Medical Centre
Clayton, Victoria, Australia
St. Vincent's Hospital (Melbourne)
Fitzroy, Victoria, Australia
Epilepsy Research Centre, Melbourne Brain Centre
Heidelberg, Victoria, Australia
The Royal Melbourne Hospital
Melbourne, Victoria, Australia
University Multiprofile Hpspital for Active Treatment "Sveti Georgi" EAD, Clinic of Neurological Diseases
Plovdiv, Bulgaria
"First Multiprofile Hospital for Active Treatment - Sofia" EAD, Neurology Clinic
Sofia, Bulgaria
University of Multiprofile Hospital for Active Treatment "Aleksandrovska" EAD, Clinic of Neurological Diseases
Sofia, Bulgaria
Fakultní nemocnice Ostrava, Neurologická klinika
Ostrava, Czechia
Mediscan Group, s.r.o
Prague, Czechia
Fakultni nemocnice v Motole, Neurologická klinika
Prague, Czechia
CHU - Service Neurophysiologie Clinique
Dijon, France
Hôpital Central - CHU de Nancy - Service de Neurologie
Nancy, France
Epilepsiezentrum Berlin- Bradenburg, Epilepsieklinik "Tabor"
Bernau bei Berlin, Germany
Krankenhaus Mara gGmbH, Epilepsiezentrum Bethel
Bielefeld, Germany
Epilepsiezentrum Kork
Kehl, Germany
Országos Klinikai Idegtudományi Intézet
Budapest, Hungary
Department of Neurology, Hadassah University Hospital Ein Kerem, Kiryat Hadassah
Jerusalem, Israel
Western Galilee Hospital, Department of Neurology
Nahariya, Israel
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.